Image 1 (Image Fig1 Effectofofotherdrug Arip)
Aripiprazole Tablet
Product Images NDC 50090-6563
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50090-6563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (Image Fig2 Effectofotherdrug Dehydroaripip)
Figure 2 shows the effect of other drugs on the pharmacokinetics of Dehydro-Aripiprazole. The text provides the names of some drugs and their potential impact on the metabolism of Aripiprazole. The drugs mentioned include teocorazoe AN, mnbtr, qundre e, YPom aucer, catanzmoe A bt, famoide P wr, and foracepam ¥. The text also mentions the percentage change in pharmacokinetics and relative reference values.*
Image 3 (Image Fig3 Effectofarip Otherdrug)
Figure 3 shows the effect of Aripiprazole, a medication, on the pharmacokinetics (movement and breakdown in the body) of other drugs. The graph displays the fold change and 90% confidence intervals for various drugs, including demopmetorphan, rowarfarin, lamotrigine, valproate, litum, lorazepam, venlafaine, veniatasine, O-desmetnyheniataing, and escitalopram. The x-axis represents the change relative to the reference (without the interacting drug), ranging from 5 to 25. This information helps understand how Aripiprazole can affect the metabolism and levels of other medications in the body.*
Image 4 (Image Fig4 Effectofintrinsicfactor Arip)
Image 5 (Image Fig5 Effectofintrinsicfactor Dehydroarip)
Fig 6 (Image Fig6 Schizophreniastudy 5)
Proportion with Relapse
Figure 6 shows the Kaplan-Meier Estimation of the cumulative proportion of patients with relapse in Schizophrenia Study 5. The graph compares the relapse rates between the ARIPIPRAZOLE group and the PLACEBO group.
The number of subjects at risk is indicated for each group at different time points. However, the specific numbers are not clearly readable due to possible errors.*
7 (Image Fig7 Bipolarstudy 7)
8 (Image Fig8 Bipolarstudy 8)
9 (Image Fig9 Tourettesdisorderstudy1)
Image (Image Logo Medguide)
Logo (Image Logo Pi)
Description Image (Image Structure)
Label Image (Lbl500906563)
This is a description of a medication called ARIptpRAZOLE. It is available in a 5 MG strength and comes in a pack of 30 tablets. The product number is 6703-0. The medication is to be taken at a specific time, indicated as 8 10 7 Decces ¢, which is unclear.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
